About the Event and Its Significance
On October 23 2025, Lazarski University hosted a landmark speaking engagement featuring Prof. Arkadiusz Dudek, a leading oncologist and researcher from the world‑renowned Mayo Clinic. The lecture, titled “Breaking through Cancer’s Shield: Cancer Immunotherapy,” took place in the Lech Falandysz Auditorium at 11:00 AM and drew a diverse audience of students, faculty, clinicians, and science enthusiasts. This session offered a window into the latest breakthroughs in cancer biology and therapeutic strategies that are reshaping patient care.
Who is Prof. Arkadiusz Dudek?
Prof. Arkadiusz Dudek holds the Mayo Clinic Chair in Hematology/Oncology and chairs the Department of Transplantation and Cellular Therapy. His research portfolio spans tumor immunology, adoptive cell transfer, and the development of personalized treatments. Over the past decade, he has published more than 200 peer‑reviewed papers and has been cited over 25 000 times, underscoring his influence on the field. His expertise bridges basic science and clinical practice, making his talks highly sought after for educational institutions and healthcare audiences worldwide.
What Is Cancer Immunotherapy?
Immunotherapy harnesses the body’s immune system to recognize and eliminate malignant cells. Unlike traditional cytotoxic chemotherapy, which indiscriminately attacks dividing cells, immunotherapeutic agents target specific markers found on tumor cells or modulate immune checkpoints that normally restrain T‑cell activity. The result is a more precise, often less toxic, treatment modality that can provide durable remissions.
Key Mechanisms Covered in the Lecture
- Checkpoint Inhibitors: Drugs such as nivolumab and pembrolizumab block PD‑1/PDL‑1 pathways, liberating T‑cells to attack tumors.
- CAR‑T Cell Therapy: Chimeric Antigen Receptor T‑cells are engineered to bind tumor antigens like CD19, enabling targeted killing of cancer cells.
- Oncolytic Virus Therapy: Viruses are designed to selectively infect and destroy tumor cells while stimulating an anti‑tumor immune response.
- Adoptive Cell Transfer: Natural killer cells and tumor‑infiltrating lymphocytes can be expanded ex vivo and re‑introduced to attack cancer.
Clinical Impact
In the lecture, Prof. Dudek highlighted real‑world data from Mayo Clinic’s clinical trials, noting substantial survival gains in patients with previously refractory cancers. For example, the use of CAR‑T therapy in acute lymphoblastic leukemia has moved from experimental to standard of care for certain patient groups, with long‑term remission rates exceeding 70 %. Such statistics demonstrate the transformative potential of immunotherapy and its expanding role across multiple tumor types.
Field of Study Highlights at Lazarski University
While the lecture focuses on oncology, the insights presented resonate across Lazarski University’s faculty offerings:
- Faculty of Medicine: Students can integrate immunology modules with clinical rotations, preparing for careers as future oncologists.
- Faculty of Economics and Management: Emerging health‑tech entrepreneurs can leverage knowledge about market dynamics driven by breakthrough therapies.
- Faculty of Law and Administration: Legal scholars may examine regulatory frameworks governing immunotherapy approvals and intellectual property.
Key Takeaways for Attendees
Attendees walked away with actionable knowledge that can be applied in multiple contexts:
- Understanding the science behind checkpoint blockade and cell‑based therapies.
- Recognizing the importance of patient selection and biomarker testing in therapy initiation.
- Identifying current research gaps and opportunities for collaborative projects.
- Learning about the pipeline of novel agents entering clinical trials.
- Gaining perspective on startups and translational pathways from bench to bedside.
How to Leverage This Knowledge
Whether you are a student, a clinician, a researcher, or an entrepreneur, the following steps can help you apply what you’ve learned:
- Enroll in Lazarski’s advanced courses on immunology and oncology to deepen your technical foundation.
- Participate in joint research projects through the university’s research institutes, which maintain ties with Mayo Clinic.
- Attend future seminars and workshops that focus on translational medicine and biotech entrepreneurship.
- Engage with the university’s alumni network to connect with professionals who are actively working in the field.
- Consider applying for postgraduate studies in medical science or health‑tech management to build a career at the intersection of science and industry.
Future Perspectives on Cancer Treatment
Prof. Dudek’s presentation also touched on emerging trends that may shape oncology over the next decade:
- Combination therapies that pair checkpoint inhibitors with oncolytic viruses or metabolic modulators.
- Personalized neoantigen vaccines tailored to each patient’s tumor mutation profile.
- Digital health platforms that monitor immune response in real time, allowing dynamic dose adjustments.
- Expanding CAR‑T therapy to solid tumors through novel targeting strategies.
- Leveraging artificial intelligence to predict therapy response and design bespoke treatment regimens.
How Lazarski University Supports Innovation
Through its Center for Postgraduate Education, the Faculty of Medicine, and extensive international collaborations, Lazarski University offers infrastructure for cutting‑edge research:
- Dedicated laboratories equipped with CRISPR, flow cytometry, and high‑throughput sequencing capabilities.
- Funding opportunities, including European structural funds and national grants, to support early‑stage projects.
- Entrepreneurial programs that accelerate the transition from discovery to market, connecting researchers to investors.
- Clinical trial support that aligns with Mayo Clinic’s standards, ensuring rigorous data collection and regulatory compliance.
- Mentorship from experienced clinicians and scientists who shape the next generation of leaders in oncology.
Actionable Steps for Prospective Students
Students interested in a career that intersects cancer research and clinical practice may consider the following:
- Apply for Lazarski’s Master’s program in Molecular Medicine, which offers modules on immunology and therapeutic development.
- Seek internship placements at local hospitals or biotech firms to gain hands‑on experience.
- Attend national conferences like the annual oncology symposium to network with industry experts.
- Write a research proposal or literature review on a subtopic from the lecture, such as CAR‑T therapy challenges.
- Stay updated with the latest journal publications by following journals like Nature Medicine and Clinical Cancer Research.
Conclusion and Next Steps
The lecture by Prof. Arkadiusz Dudek exemplifies the powerful synergy between academic insight and clinical innovation. By attending such talks and engaging with Lazarski University’s robust programs, students and professionals can position themselves at the forefront of cancer therapy advancements.
Take Action Now
Ready to build a career in oncology or medical innovation? Explore Lazarski’s programs and discover the next steps that align with your goals.
For personalized guidance on course selection and admission requirements, schedule a consultation with our admissions team today.
Have questions about the content of the lecture or how to apply cancer immunotherapy in your practice? Contact us, and we’ll connect you with the right experts.
Share your thoughts on how breakthrough therapies could change healthcare—leave a comment below or join the discussion on our social media channels to connect with peers.
